Sheng Z, Beck P, Gabby M, Habte-Mariam S, Mitkos K
Cancers (Basel). 2025; 17(1).
PMID: 39796708
PMC: 11720314.
DOI: 10.3390/cancers17010077.
Kono Y, Pack C, Ichikawa T, Komatsubara A, Adam S, Miyazawa K
PNAS Nexus. 2024; 3(12):pgae527.
PMID: 39677369
PMC: 11645434.
DOI: 10.1093/pnasnexus/pgae527.
Biffi R, Benoit S, Sariyer I, Safak M
Tumour Virus Res. 2024; 18:200298.
PMID: 39586476
PMC: 11647237.
DOI: 10.1016/j.tvr.2024.200298.
Prajapat M, Sala L, Vidigal J
RNA. 2024; 30(11):1465-1476.
PMID: 39209555
PMC: 11482604.
DOI: 10.1261/rna.080161.124.
Shao X, Xu H, Kim H, Ljaz S, Beier F, Jankowski V
Cell Death Discov. 2024; 10(1):364.
PMID: 39143064
PMC: 11324798.
DOI: 10.1038/s41420-024-02131-y.
Selective regulation of chemosensitivity in glioblastoma by phosphatidylinositol 3-kinase beta.
Pridham K, Hutchings K, Beck P, Liu M, Xu E, Saechin E
iScience. 2024; 27(6):109921.
PMID: 38812542
PMC: 11133927.
DOI: 10.1016/j.isci.2024.109921.
BRCA2 promotes genomic integrity and therapy resistance primarily through its role in homology-directed repair.
Lim P, Zaman M, Feng W, Jasin M
Mol Cell. 2024; 84(3):447-462.e10.
PMID: 38244544
PMC: 11188060.
DOI: 10.1016/j.molcel.2023.12.025.
AGO2 silences mobile transposons in the nucleus of quiescent cells.
Sala L, Kumar M, Prajapat M, Chandrasekhar S, Cosby R, La Rocca G
Nat Struct Mol Biol. 2023; 30(12):1985-1995.
PMID: 37985687
DOI: 10.1038/s41594-023-01151-z.
Cancer-associated fibroblasts actively compress cancer cells and modulate mechanotransduction.
Barbazan J, Perez-Gonzalez C, Gomez-Gonzalez M, Dedenon M, Richon S, Latorre E
Nat Commun. 2023; 14(1):6966.
PMID: 37907483
PMC: 10618488.
DOI: 10.1038/s41467-023-42382-4.
CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression.
Terry A, Nogueira V, Rho H, Ramakrishnan G, Li J, Kang S
Cell Metab. 2023; 35(11):2060-2076.e9.
PMID: 37852255
PMC: 11748917.
DOI: 10.1016/j.cmet.2023.09.012.
Deregulated expression of the 14q32 miRNA cluster in clear cell renal cancer cells.
Chhabra R, Guergues J, Wohlfahrt J, Rockfield S, Espinoza Gonzalez P, Rego S
Front Oncol. 2023; 13:1048419.
PMID: 37139155
PMC: 10150008.
DOI: 10.3389/fonc.2023.1048419.
Familial CCM Genes Might Not Be Main Drivers for Pathogenesis of Sporadic CCMs-Genetic Similarity between Cancers and Vascular Malformations.
Zhang J, Croft J, Le A
J Pers Med. 2023; 13(4).
PMID: 37109059
PMC: 10143507.
DOI: 10.3390/jpm13040673.
Generation of human immortalized chondrocytes from osteoarthritic and healthy cartilage : a new tool for cartilage pathophysiology studies.
Pineiro-Ramil M, Sanjurjo-Rodriguez C, Rodriguez-Fernandez S, Hermida-Gomez T, Blanco-Garcia F, Fuentes-Boquete I
Bone Joint Res. 2023; 12(1):46-57.
PMID: 36647698
PMC: 9872042.
DOI: 10.1302/2046-3758.121.BJR-2022-0207.R1.
ZAP70 Activation Compensates for Loss of Class IA PI3K Isoforms Through Activation of the JAK-STAT3 Pathway.
Demir M, Cizmecioglu O
Cancer Diagn Progn. 2022; 2(3):391-404.
PMID: 35530641
PMC: 9066532.
DOI: 10.21873/cdp.10122.
Development of human alveolar epithelial cell models to study distal lung biology and disease.
Tran E, Shi T, Li X, Chowdhury A, Jiang D, Liu Y
iScience. 2022; 25(2):103780.
PMID: 35169685
PMC: 8829779.
DOI: 10.1016/j.isci.2022.103780.
Distinct Oncogenic Transcriptomes in Human Mammary Epithelial Cells Infected With Cytomegalovirus.
Haidar Ahmad S, Pasquereau S, El Baba R, Nehme Z, Lewandowski C, Herbein G
Front Immunol. 2022; 12:772160.
PMID: 35003089
PMC: 8727587.
DOI: 10.3389/fimmu.2021.772160.
Development of novel agents for the treatment of early estrogen receptor positive breast cancer.
Elliott M, Cescon D
Breast. 2021; 62 Suppl 1:S34-S42.
PMID: 34903444
PMC: 9097798.
DOI: 10.1016/j.breast.2021.11.007.
Generation of Mesenchymal Cell Lines Derived from Aged Donors.
Pineiro-Ramil M, Sanjurjo-Rodriguez C, Rodriguez-Fernandez S, Castro-Vinuelas R, Hermida-Gomez T, Blanco-Garcia F
Int J Mol Sci. 2021; 22(19).
PMID: 34639008
PMC: 8508916.
DOI: 10.3390/ijms221910667.
The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings.
Shor R, Dai J, Lee S, Pisarsky L, Matei I, Lucotti S
Mol Oncol. 2021; 16(1):130-147.
PMID: 34058066
PMC: 8732345.
DOI: 10.1002/1878-0261.13031.
Differential substrate use in EGF- and oncogenic KRAS-stimulated human mammary epithelial cells.
Keibler M, Dong W, Korthauer K, Hosios A, Moon S, Sullivan L
FEBS J. 2021; 288(19):5629-5649.
PMID: 33811729
PMC: 8487438.
DOI: 10.1111/febs.15858.